2m 2m 2m 2m 2m 2m 2m
IMMUNEERING-A (IMRX)
NASDAQ
$4.34+$0.07 (+1.52%)
Price as of Sep 11, 2026 7:30 PM EDT- $276.3MMarket Cap
- -49.71%1-Year Change
- BiotechnologyIndustry
IMMUNEERING-A (IMRX)
$4.34+$0.07 (+1.52%)
IMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.27 | ||
Change | -$0.30 (-6.56%) | ||
Open | $4.63 | ||
High | $4.65 | ||
Low | $4.24 | ||
Previous Close | $4.57 | ||
Volume | 911,042 | ||
30-Day Average Volume | 675,497 | ||
1-Week Change | -11.41% | ||
1-Month Change | -11.04% | ||
1-Year Change | -49.71% | ||
3-Year Change | -45.40% | ||
5-Year Change | -79.42% | ||
Fundamentals | |||
Shares Outstanding | 64.7M | ||
Total Assets | $202.1M | ||
Market Cap | $276.3M | ||
Enterprise Value | $234.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$17.3M | ||
Free Cash Flow | -$16.5M | ||
EBIT | -$17.3M | ||
EBITDA | -$17.3M | ||
Net Working Capital | $149.9M | ||
EPS | -$0.27 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -16 | ||
PEG | 1 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue